European journal of endocrinology · 2026
Correct neonatal free thyroxine reference intervals are crucial to detect central congenital hypothyroidism.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Garrelfs Mark R, Lauffer Peter, Hillebrand Jacquelien J, Heijboer Annemieke C, Boelen Anita, van Trotsenburg A S Paul, Zwaveling-Soonawala Nitash
Аннотация
OBJECTIVE: In the Netherlands, after an abnormal newborn screening (NBS) result suggestive of central congenital hypothyroidism (CH), children are referred for confirmatory plasma-free thyroxine (fT4) measurement. Correct interpretation of these results relies on appropriate age- and assay-specific reference intervals (RI), which are often not available. The current study was performed to check whether the use of adult or other incorrect fT4 RIs during the post-screening work-up of neonates with an abnormal NBS had led to missed diagnoses of central CH.
DESIGN: Retrospective cohort study with prospective re-evaluation.
METHODS: Children born between 1 March 2018 and 1 April 2021 with an abnormal NBS result suggesting central CH were identified through the Dutch national screening registry (NEORAH). Children classified as having a "false positive" screening result based on post-screening confirmatory fT4 concentrations in the neonatal period were included if those fT4 concentrations were ≤ 3 pmol/L above the assay-specific lower limit of the adult RI. After obtaining informed consent, re-evaluation of thyroid function was performed.
RESULTS: Six children were identified and informed consent was obtained from four participants. Two out of four participants received a new diagnosis of central CH, including one case of multiple pituitary hormone deficiencies (MPHD).
CONCLUSIONS: This study highlights the critical need for age- and assay-specific RIs for plasma fT4 to accurately diagnose central CH in the neonatal period.
DESIGN: Retrospective cohort study with prospective re-evaluation.
METHODS: Children born between 1 March 2018 and 1 April 2021 with an abnormal NBS result suggesting central CH were identified through the Dutch national screening registry (NEORAH). Children classified as having a "false positive" screening result based on post-screening confirmatory fT4 concentrations in the neonatal period were included if those fT4 concentrations were ≤ 3 pmol/L above the assay-specific lower limit of the adult RI. After obtaining informed consent, re-evaluation of thyroid function was performed.
RESULTS: Six children were identified and informed consent was obtained from four participants. Two out of four participants received a new diagnosis of central CH, including one case of multiple pituitary hormone deficiencies (MPHD).
CONCLUSIONS: This study highlights the critical need for age- and assay-specific RIs for plasma fT4 to accurately diagnose central CH in the neonatal period.